CPCB Effluent Discharge Standards for Hospitals — Explained

Hospital wastewater is among the most hazardous categories of effluent in India — it carries a cocktail of pathogenic microorganisms, pharmaceutical residues, and heavy metals that domestic sewage treatment systems are not designed to handle. CPCB has set specific effluent discharge standards for hospitals under the Environment (Protection) Rules 1986, and the Bio-Medical Waste Management Rules 2016 govern the parallel solid waste stream.

This article explains the applicable discharge limits, what they require in practice, how to correctly distinguish between biomedical waste and hospital wastewater, how to design a compliant hospital STP, and the emerging concern of antibiotic-resistant organisms in hospital discharge.

About This CPCB Standard

Hospital effluent discharge standards in India are set under Schedule VI of the Environment (Protection) Rules 1986, which prescribes effluent standards for various industrial and institutional categories. Hospitals fall under the "Hospitals / Health Care Establishments" category for discharge to inland surface water.

Simultaneously, the Bio-Medical Waste Management Rules 2016 (amended 2018 and 2019) govern the management, treatment, and disposal of solid biomedical waste — a distinct regulatory regime that operates alongside the effluent standards. Understanding the boundary between the two frameworks is essential for compliance.

The regulatory authority for both frameworks at the central level is CPCB (Central Pollution Control Board). At the state level, compliance is enforced by the respective State Pollution Control Board (SPCB) or Pollution Control Committee (PCC) in Union Territories.

Hospital Wastewater — Pathogens, Pharmaceuticals, and High BOD

Hospital wastewater differs from ordinary domestic sewage in four important ways:

• Pathogenic microorganisms — Wastewater from general wards, operation theatres, intensive care units, and diagnostic laboratories carries a high load of disease-causing organisms: Salmonella, pathogenic E. coli, Staphylococcus aureus (including MRSA), Mycobacterium tuberculosis, hepatitis A and B viruses, and enteric viruses. Standard domestic sewage treatment provides insufficient disinfection for these pathogens.
• Pharmaceutical residues — Antibiotics, hormones, cytotoxic drugs (used in chemotherapy), contrast agents from radiology, and anaesthetic residues are present in hospital effluent. Many of these compounds are not effectively removed by conventional biological treatment and pass through to the receiving water body.
• Radioactive material — Nuclear medicine departments (PET scans, thyroid treatment with I-131) generate low-level liquid radioactive waste. This is subject to Atomic Energy Regulatory Board (AERB) guidelines and must be held in decay tanks before disposal — it is not treated in the main STP.
• Heavy metals — Mercury from thermometers and dental amalgam (in hospitals with dental departments), silver from X-ray film processing (older facilities), and disinfectants containing quaternary ammonium compounds contribute to the heavy metal load in hospital effluent.

The BOD of raw hospital wastewater is typically 150–300 mg/L — comparable to domestic sewage — but the pathogen load and pharmaceutical content make it significantly more hazardous on a public health and environmental basis.

Hospital Effluent Discharge Limits at a Glance

The following standards apply to hospital effluent discharged to inland surface water under Schedule VI of the Environment (Protection) Rules 1986:

Note that the coliform limits above are among the most demanding parameters to achieve consistently. Raw hospital wastewater typically contains fecal coliform counts in the range of 10⁶–10⁸ MPN/100 mL, requiring log-reductions of 3–5 orders of magnitude through biological treatment followed by effective disinfection.

Pathogen Removal — Mandatory Disinfection

The fecal coliform limit of 250 MPN/100 mL and total coliform limit of 1,000 MPN/100 mL make disinfection a mandatory process step in any hospital STP — biological treatment alone is insufficient to achieve these limits consistently.

Two disinfection technologies are used in hospital STPs in India:

• Chlorination — Sodium hypochlorite (NaOCl) or calcium hypochlorite is dosed into the treated effluent before a contact tank with a minimum 30-minute hydraulic retention time at the design flow rate. Chlorination is effective and inexpensive but requires careful dosing control: too little leaves pathogens alive; too much produces effluent with total residual chlorine above the 0.5 mg/L limit, requiring de-chlorination (sodium thiosulphate or activated carbon) before discharge.
• UV disinfection — Ultraviolet irradiation (typically at 254 nm wavelength) inactivates pathogens without adding residual chemicals, avoiding the chlorine limit problem. UV systems require low TSS in the feed (turbidity reduces UV penetration) and require regular lamp replacement, typically every 8,000–12,000 hours of operation. UV is increasingly preferred for hospitals with strict compliance requirements.

Hospitals using chlorination must monitor total residual chlorine in the discharged effluent as part of their routine monitoring programme. If chlorine dosing is not carefully controlled, over-dosing is a frequent violation — the treated effluent may meet coliform limits but fail the residual chlorine limit.

Biomedical Waste vs Hospital Wastewater — Critical Distinction

One of the most important compliance distinctions for hospital environmental management is the separation of biomedical waste from hospital wastewater. These two streams are regulated under different laws and must be managed through completely separate pathways.

Biomedical waste — regulated under the Bio-Medical Waste Management Rules 2016 — includes:

• Human anatomical waste (body parts, tissues, organs)
• Pathological waste (blood bags, blood samples, body fluids)
• Sharps (needles, syringes with fixed needles, blades, scalpels)
• Soiled waste (items contaminated with blood and body fluids — dressings, cotton, gloves)
• Solid pharmaceutical waste (expired and discarded medicines)
• Chemical waste (chemical used in diagnostic and therapeutic procedures)
• Cytotoxic pharmaceutical waste (from chemotherapy)

All biomedical waste must be segregated at source (by colour-coded bags and containers), stored in a dedicated biomedical waste storage area, and collected by and sent to an authorised Common Biomedical Waste Treatment Facility (CBWTF). It must never be disposed of through the hospital STP.

Hospital wastewater — regulated under the Environment (Protection) Rules 1986 — consists of liquid effluent from:

• Toilets, bathrooms, and sinks in wards and common areas
• Kitchen and canteen drains
• Operation theatre floor drains (liquid wash-down, not solid waste)
• Laboratory drain lines (liquid chemical and biological waste in solution)
• Laundry wastewater
• Cooling tower blowdown and HVAC condensate

This liquid stream goes to the hospital STP. The critical rule: solid biomedical waste must not enter the liquid drain system. A single break in segregation — such as soiled dressings or syringes entering a floor drain — can cause the STP to fail regulatory limits and create a serious public health risk.

STP Design for Hospitals — Key Sizing and Process Considerations

Hospitals above 30 beds require a dedicated STP. The standard process train for a compliant hospital STP is:

1. Collection sump and inlet pumping station — all hospital drain lines converge to an underground collection sump. Screen and pump station lift the flow to the treatment units.
2. Screening — coarse bar screen (10–15 mm) followed by a fine screen (1–3 mm) to remove gross solids. Fine screening is important in hospitals to capture any solid material that has inadvertently entered the drain system.
3. Equalisation tank — hospitals have significant diurnal flow variation (peak in morning and early afternoon, low flow at night). An equalisation tank of 6–8 hours HRT smooths the flow and load to downstream biological units.
4. Primary settling — removes settleable solids before biological treatment. Some compact hospital STP designs skip primary clarification and rely on equalisation followed directly by biological treatment.
5. Biological treatment — the two most common processes for hospital STPs in India are:
   • Extended Aeration Activated Sludge Process (ASP) — conventional, well-understood, suitable for larger hospitals. Sludge wasting and management require operator attention.
   • Moving Bed Biofilm Reactor (MBBR) — preferred for compact hospital sites where footprint is limited. MBBR systems have a smaller footprint than conventional ASP for the same capacity and are more resilient to load fluctuations. The ammoniacal nitrogen limit of 50 mg/L requires nitrification, which MBBR handles well with appropriate media fill ratio.
6. Secondary clarifier — separates biological sludge from treated effluent. Return sludge is recycled to the aeration tank; excess sludge is wasted to sludge drying beds or a mechanical dewatering unit.
7. Disinfection — chlorination contact tank (30 min HRT) or UV disinfection unit to meet the coliform limits. See the pathogen removal section above.
8. Polishing filter — a pressure sand filter or multi-grade filter polishes the effluent to achieve TSS ≤100 mg/L before discharge. Important for meeting TSS consistently, particularly after sludge bulking events in the biological stage.
9. Final discharge or reuse — treated effluent meeting all consent limits is discharged to the approved outlet. Many hospitals are now designing for partial reuse of treated effluent for toilet flushing and landscaping, reducing freshwater demand.

Sizing basis: For design flow, a common rule of thumb is 300–400 litres per bed per day (L/B/D) for a general hospital with in-patient wards, OT, kitchen, and laundry. Specialist hospitals (cancer, dialysis, maternity) may have different flows. Always measure actual water supply consumption for 30 days and use 80% of that as the STP design flow — this is more reliable than bed-based rules of thumb for established hospitals.

Antibiotic-Resistant Bacteria — An Emerging Compliance Concern

Antibiotic-resistant organisms (AROs) — including MRSA (Methicillin-resistant Staphylococcus aureus), carbapenem-resistant Klebsiella, and extended-spectrum beta-lactamase (ESBL) producing E. coli — are present in hospital wastewater at concentrations significantly higher than in domestic sewage. This is because hospitals are the primary site of antibiotic use and antibiotic-resistant infections in India.

As of 2026, CPCB has not yet prescribed a formal discharge standard for antibiotic-resistant organisms or antibiotic residue concentrations in hospital effluent. However:

• CPCB has been conducting monitoring studies of AMR (antimicrobial resistance) in river water near hospital discharge points, particularly in the Ganga basin. Hospitals near National River Monitoring Programme (NRMP) monitoring stations should be aware that this data may inform future regulatory action.
• The National Action Plan on Antimicrobial Resistance (NAP-AMR) 2017–2021 (extended) specifically identifies hospital wastewater as a transmission route for AROs into the environment. Regulatory tightening in this area is expected over the coming years.
• Hospitals that implement effective biological treatment followed by UV disinfection (rather than chlorination alone) achieve better removal of AROs and antibiotic residues — a proactive compliance position ahead of likely future standards.

For hospitals seeking to future-proof their STP design against likely AMR-related standards, advanced treatment steps such as ozonation or activated carbon polishing can be incorporated into the process train. These are currently above minimum CPCB requirements but represent best practice for large tertiary care hospitals.

Monitoring Requirements and Enforcement

Hospitals classified as Red Category industries (above 30 beds) are subject to the following monitoring and compliance requirements:

• Quarterly effluent testing — NABL-accredited third-party laboratory testing of the final treated effluent is required every quarter. The test report must cover all parameters in the consent conditions (at minimum: pH, BOD, COD, TSS, oil and grease, ammoniacal nitrogen, total coliform, fecal coliform, and total residual chlorine).
• Online Effluent Monitoring System (OEMS) — hospitals above a certain size (bed strength varies by state SPCB notification) may be required to install an online effluent quality monitoring system connected to the SPCB real-time data server. Parameters monitored online typically include pH, BOD (estimated), COD, TSS, and flow rate.
• Consent to Operate (CTO) renewal — CTO for Red Category facilities is renewed every two years. Renewal requires submission of compliance monitoring reports, STP operational records, and biomedical waste manifest records.
• Biomedical waste annual report — under the Bio-Medical Waste Management Rules 2016, hospitals must submit an annual report to the SPCB detailing the quantity of biomedical waste generated by category, the CBWTF used, and the waste manifest records.
• SPCB inspections — Red Category facilities are subject to periodic SPCB inspections. Inspectors check STP operational records (logbooks), effluent test reports, biomedical waste storage area, waste manifest records, and may take independent effluent samples for testing.

Common enforcement actions for non-compliant hospitals include show-cause notices demanding compliance within 30–90 days, closure directions for serious violations, and environmental compensation demands under the Polluter Pays principle. Non-compliance with biomedical waste rules can additionally result in criminal prosecution under the Environment Protection Act 1986.

For hospitals seeking to ensure STP compliance before a CTO renewal or SPCB inspection, an independent compliance audit of the STP — covering process performance, monitoring records, and biomedical waste segregation practices — is the most effective preparation.